InsiderSignal.AI

InsiderSignal.ai

MANE - Veradermics, Inc

Insider Purchase by Childs John W (Dir)

3 Months
After Trade
Before Trade

Loading data...

Trade Summary

2 months ago, Childs John W, serving as Dir at Veradermics, Inc (MANE), purchased 294,117 shares at $17.00 per share, for a total transaction value of $4,999,989.00. Following this transaction, Childs John W now holds 2,202,006 shares of MANE.

This purchase represents a 15.00% increase in Childs John W's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, February 5, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, February 5, 2026, meaning the disclosure happened on the same day as the trade.

Veradermics, Inc operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Childs John W

Dir

John W. Childs is an accomplished private equity executive serving as an Independent Director at Biohaven Ltd. (NYSE: BHVN) since September 2022.[[2]](https://www.biohaven.com/about/board-of-directors/)[[5]](https://app.boardroomalpha.com/profiles/people/A1002910-JOHN_W_CHILDS) He is the Chairman and Partner of J.W. Childs Associates, L.P., a private equity firm he co-founded in 1995, focusing on life sciences, real estate, and consumer brands.[[2]](https://www.biohaven.com/about/board-of-directors/)[[3]](https://coolidgefoundation.org/the-foundation-historic-site/foundation/john-w-childs/) Previously, he was Senior Managing Director at Thomas H. Lee Company (1991-1995), managing leveraged buyouts, and spent 17 years at Prudential Insurance Company in investment roles.[[2]](https://www.biohaven.com/about/board-of-directors/) Childs has a distinguished board career, including past Chairmanships at CHG Healthcare Services, Sunny Delight, and Kosta Browne, and current directorships at Realm, LLC (premium Napa wines), Pyramid Biosciences, OMAX Health, and Basin Holdings.[[2]](https://www.biohaven.com/about/board-of-directors/)[[3]](https://coolidgefoundation.org/the-foundation-historic-site/foundation/john-w-childs/) On November 13, 2025, he purchased 3,333,333 common shares of Biohaven for $25 million at $7.50 per share, increasing his holdings by 52%, signaling strong confidence in the company.[[1]](https://www.investing.com/news/insider-trading-news/biohaven-ltd-director-childs-buys-25m-in-common-shares-93CH-4362079)[[4]](https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-bhvn/biohaven/news/independent-director-of-biohaven-john-childs-buys-52-more-sh) He holds a B.A. from Yale University and an M.B.A. from Columbia University.[[2]](https://www.biohaven.com/about/board-of-directors/)[[3]](https://coolidgefoundation.org/the-foundation-historic-site/foundation/john-w-childs/)

View full insider profile →

Trade Price

$17.00

Quantity

294,117

Total Value

$4,999,989.00

Shares Owned

2,202,006

Trade Date

Thursday, February 5, 2026

60 days ago

SEC Filing Date

Thursday, February 5, 2026

HEALTHCAREBIOTECHNOLOGY

About Veradermics, Inc

Company Overview

No company information available
View news mentioning MANE

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/3730852

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime